Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery-Reference-Cited by-同舟云学术

Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery

Published:2017 Issue: Volume: Page:20-64
ISSN:
Container-title:Comprehensive Medicinal Chemistry III
language:
Short-container-title:

Author:

Mercier J.,Provins L.,Hannestad J.

Publisher

Elsevier

Reference351 articles.

1. Molecular Imaging That Will Bring About a Revolution in Diagnosis and Drug Discovery: How Positron Emission Tomography Works;Suzuki;Riken Res.,2009

2. Can the Pharmaceutical Industry Reduce Attrition Rates?;Kola;Nat. Rev. Drug Discov.,2004

3. True Alignment of Preclinical and Clinical Research to Enhance Success in CNS Drug Development: A Review of the Current Evidence;Goetghebeur;J. Psychopharmacol.,2016

4. Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use;George;CNS Drugs,2015

5. Integrative Processes: Neuroscience Clinical Imaging Biomarkers;Grachev,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in the Exploration of Esterases with PET and Fluorescent Probes;Molecules;2023-08-27

2. Late‐stage Functionalization of Pharmaceuticals, Agrochemicals, and Natural Products;Transition‐Metal‐Catalyzed C‐H Functionalization of Heterocycles;2023-03-25

3. Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders;Inflammopharmacology;2022-10-22

4. The Effect of Meclofenoxate on the Transcriptome of Aging Brain of Nothobranchius guentheri Annual Killifish;International Journal of Molecular Sciences;2022-02-24

5. Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview;Biomedicines;2020-10-15